The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy (Q39735076)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy |
scientific article |
Statements
1 reference
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy (English)
1 reference
Tihui Fu
1 reference
Qiuming He
1 reference
Padmanee Sharma
1 reference
27 June 2011
1 reference
1 reference
71
1 reference
16
1 reference
5445-5454
1 reference
Identifiers
1 reference
1 reference